Health Costs For Alzheimer's Patients Higher Before Diagnosis
the Psychiatry Advisor take:
Health care costs for people diagnosed with Alzheimer’s disease (AD) increase a year before the diagnosis is even made.
Researchers at the University of Eastern Finland, using data from the Finnish Medication Use and Alzheimer's Disease Study, Medalz, involving over 70,000 AD patients found that most of the health care costs (78-84%) for these patients comes from hospital care.
The costs of drug therapy were analyzed as overall costs, and the costs of hospital days were calculated according to the Finnish health care system's unit costs, which also include the patient's payment contribution.
The difference in health care costs between AD and non-AD patients were highest six months after diagnosis, with AD patients having, on average $5436 higher costs per person, annually. And although the difference evened out after six months, two years after diagnosis, AD patients health care costs stabilized at twice that of non-AD patients, the researchers reported in the Journal of Public Health.
Five years before diagnosis, Alzheimer’s patients had, on average, 1.4 more hospitals days per year than non-AD patients. Two years after diagnosis, that figur jumped to 14.2 more hospital days.
Health care costs for people diagnosed with Alzheimer’s disease increase a year before the diagnosis is even made.
The health care costs of patients diagnosed with Alzheimer's disease (AD) start to increase already one year before the diagnosis, shows a new study from the University of Eastern Finland.
The differences in the health care costs between AD patients and non-AD patients were the greatest during six months following the diagnosis, with AD patients having 5,088 euros higher health care costs per person-year. After the first six months, the differences evened out. Two years after the diagnosis, the health care costs of AD patients stabilized at a level two times higher than that of non-AD patients.
The majority of the health care costs of AD patients, i.e. 78-84%, were caused by hospital care and only a fraction by drug therapy. Anti-dementia drugs initiated after the diagnosis explained the majority of the drug costs
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- Antidepressant Use May Be Linked With Sustained Risk for Weight Gain
- New APA President Takes Office as the First African-American to Lead the Organization
- MDMA-Assisted Psychotherapy Effective for Treating PTSD in Veterans, First Responders
- Substance Abuse and Primary Psychosis: A Closer Look
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Cannabidiol Not Associated With Improvement in Chronic Schizophrenia
- Methadone Maintenance Therapy Associated With Greater Access to Physician Care in HCV-Positive Drug Users
- New Dimensions in Psychopathy: Are There Cultural Differences in Psychopaths?
- Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases
- Exploring the Link Between Persistent Infection, Inflammation, and Mood Disorders
- CDC: No Change in Level of Uninsured in US in 2017
- Benefit of Behavioral Activation During TMS for Major Depressive Disorder